Skip to Content

XELODA 150 (Xeloda 150 mg)

Generic Name: capecitabine

Pill with imprint XELODA 150 is Pink, Elliptical / Oval and has been identified as Xeloda 150 mg. It is supplied by Roche Laboratories.

Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for XELODA 150

Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150
Xeloda 150 mg XELODA 150

Xeloda

Generic Name
capecitabine
Imprint
XELODA 150
Strength
150 mg
Color
Pink
Size
11.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roche Laboratories
Inactive Ingredients
croscarmellose sodium, lactose anhydrous, microcrystalline cellulose, magnesium stearate, water, magnesium silicate, titanium dioxide, ferric oxide red, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00004-1100 Roche
54868-4143 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.